![[115] Cannabinoids for Chronic Pain](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/11/115-150x150.png)
Canada's parliament legalized the recreational use of herbal cannabis (marijuana) in October 2018. The well-publicized limitations of clinical research and well-recognized side effects such as cannabis intoxication have not deterred people from … Read More
What’s New
![[114] Shingrix: A New Vaccine for Shingles](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/10/114-150x150.png)
[114] Shingrix: A New Vaccine for Shingles
Herpes zoster (HZ) or “shingles” occurs when the varicella zoster virus (VZV), lying latent in the sensory ganglia, becomes reactivated. An HZ outbreak typically presents as a vesicular skin eruption most characteristically forming a painful girdle … Read More
![[113] How well do you know your anticholinergic (antimuscarinic) drugs?](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/09/113-150x150.png)
[113] How well do you know your anticholinergic (antimuscarinic) drugs?
Anticholinergic drugs, prescribed for a variety of clinical conditions, are amongst the most frequently used prescription drugs in BC (Table 1). Also referred to as “antimuscarinics,” such drugs specifically block muscarinic receptors for … Read More
![[112] Antidepressant Withdrawal Syndrome](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/07/112-150x115.png)
[112] Antidepressant Withdrawal Syndrome
Antidepressant drugs are associated with drug tolerance, dependence and a discontinuation syndrome similar to other drug classes such as the opiates and benzodiazepines. The effects of stopping any antidepressant should be more precisely termed … Read More
![[111] Deprescribing Proton Pump Inhibitors](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2018/06/111-150x150.png)
[111] Deprescribing Proton Pump Inhibitors
The first PPI was approved in Canada in 1988. Pronounced and durable reduction of stomach acid production made omeprazole a “blockbuster drug”, spawning multiple imitators. Eventually this included (as patent extensions) the single enantiomers … Read More
Join the Conversation
New UBC Therapeutics Initiative Letter 115:
Cannabinoids for Chronic Pain:
we currently "lack good evidence that any cannabis-derived product works for chronic pain"
#cannabinoids #cannabis #chronicpain College of Pharmacists of BC College of Physicians and Surgeons of BC
